George Steuart Health (GS Health) is one of Sri Lanka’s foremost distributors of pharmaceutical and non-pharmaceutical products. Over three decades of operations, the company has built a formidable network of agency partnerships with over 70 global healthcare giants in 15 countries, including world leading manufacturers such as B braun (Germany), Abbott (United States) and Celltrion (South Korea) as well as Unique Pharmaceuticals (India), Biopharm (Thailand), United Laboratories (Philippines), Nabiqasim (Pakistan) and Centaur (India).
The George Steuart Health advantage has been its deep knowledge of the healthcare space in Sri Lanka and a commitment to understand and cater to the needs of the medical community, thereby sourcing products that match medical requirements and enable better outcomes. It has established an extensive trade presence in Sri Lanka spanning over 5,100 outlets, including pharmacies, stocking doctors and modern trade. The company employs a well-trained, knowledgeable field force of over 300 representatives nationwide and is well supported by a distribution network that is renowned for its modern infrastructure and state- of-the-art warehousing.
In an intensely competitive market, George Steuart Health has consistently been ranked among the top three players in the pharmaceutical segment, which represents the largest share of the company’s revenue. It markets over 600 pharmaceutical products in recognised formulations across all therapeutic segments.
George Steuart Health engages in over 15 other non- pharmaceutical product categories such as diagnostics, surgical devices, medical devices, neutraceuticals, cosmetics, veterinary medicines, sports fitness and rehabilitation, and optometry. Its consumer division markets a suite of health and wellness products, representing international brands.
George Steuart Health was instrumental in revolutionising the diagnostics landscape in Sri Lanka with the introduction of rapid diagnostics in 2009, which has led to the improvement of detection and treatment of diseases such as Dengue Fever, Influenza, AIDS and Covid-19, and a many other infectious diseases.
Currently 90% of the total of sales of the George Steuart Health is generated from the private sector while the rest is accounted by the state sector.
